Ground News

News from LifeArc

All of today’s top news stories from LifeArc. Get the full analysis behind how media bias impacts breaking news.

In total, 8 have been published by LifeArc which Ground News has aggregated in the past 3 months.

The Ground News media bias check for LifeArc is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

We’ve assigned a rating of Unknown factuality to LifeArc. You can read more about how we’ve determined LifeArc’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

Information about LifeArc

Where is LifeArc located?LifeArc's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top LifeArc News

NHS · London

LifeArc and Genetic Alliance UK launch a new report calling for the acceleration of research and development (R&D) for rare diseases

LifeArc and Genetic Alliance UK have launched a report calling for the UK Government, NHS, researchers, industry, patient groups and policymakers to work together to transform the lives of more than 3.5 million people in the UK living with a rare disease. LifeArc assembled a Taskforce of stakeholders from across the UK rare disease and life sciences landscape to develop the report ‘Accelerating R&D for rare disease in the UK: An opportunity to …Read Article

University Student

'Connections' Between Ontario University Students and Dementia Patients Goal of New Partnership

The Alzheimer Society of Durham Region is teaming up with Trent University Durham GTA to strengthen community-based research that improves lives of people living with dementia. The collaboration is expected to bridge generations to reduce social isolation and create opportunities for applied learning, said Trent Durham GTA Vice-President Scott Henderson. “This partnership reflects Trent’s mission to engage students in learning that meaningfully …See the Story

Artificial Intelligence · United Kingdom

Neurizon Creates Liquid Formula to Improve Accessibility of ALS Treatment

NUZ develops oral liquid formula of NUZ-001 ALS treatment Company expects to both improve patient experience and drugs commercial potential New formula to be included in upcoming human clinical trials Special Report: Neurizon Therapeutics has developed a new oral liquid formulation of its NUZ-001 drug for the treatment of Amyotrophic Lateral Sclerosis (ALS) in a move expected to improve accessibility and ease administration of the treatment. T…See the Story

LifeArc launches first study of Our Future Health data using in-house data science capabilities

Our Future Health holds rich, in-depth data on its consented participants. For future research and the development of new tests and treatments, it’s important that researchers can analyse and study the data of participants who share certain health characteristics. We joined Our Future Health as a founding charity member in 2024 and are now launching our first study. The study – CohorTS* – will use our in-house data science capabilities to gro…United Kingdom · United Kingdom Read Article

LifeArc appoints new General Counsel and Company Secretary and Chief Communications Officer

We have appointed two new members to our executive team: Jan Lasik as our new General Counsel and Company Secretary, and Claire Pimm as our new Chief Communications Officer. About Jan Lasik In his new role, Jan will act as a strategic advisor to our Board and executive team, overseeing legal and governance across the organisation and working to help mitigate risk. Jan joins us from the National Trust, where he was a member of the executive tea…United Kingdom · United Kingdom Read Article

Avant Technologies and Ainnova Explore Integrating Early Detection of Dementia into AI-Powered Preventative Screening Platform

100% Left coverage: 2 sources

LAS VEGAS, NEVADA / ACCESS Newswire / May 27, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial…Dementia · Las Vegas See the Story

LifeArc Joins Transatlantic Collaboration to Develop a Treatment for Crimean-Congo Hemorrhagic Fever

A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic Fever Virus (CCHFV), which could treat and protect thousands of people globally.Frederick, Maryland · Frederick See the Story

LifeArc joins the REMEDi4ALL Consortium, a pioneering global platform shaping the future of drug repurposing

LifeArc and the EU-funded project, REMEDi4ALL, have announced a collaboration agreement to strengthen the partnership’s potential to transform and accelerate the repurposing of medicines in Europe. Focusing on drug repositioning The agreement reflects the increased interest in drug repositioning and repurposing as a faster, more cost-effective strategy to complement de novo drug development approaches. Such medicines repurposing holds particular…Medical Read Article

£1million partnership aims to develop new treatments for congenital muscular dystrophy

Researchers from University College London have jointly received a £1 million grant from LifeArc and Muscular Dystrophy UK, to develop potential treatments for congenital muscular dystrophy. Congenital muscular dystrophy includes a group of conditions that can lead to muscle weakness, reduced movement and tight joints. Symptoms can start from birth, or in the first few months of life, and there are currently no effective treatments. The first o…London, England · London Read Article

You've scrolled to the bottom of the feed, there are no more stories.